Follow the Connect Biopharma Holdings Ltd share price and the full directors' dealings record of the company, a listed issuer based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). Market capitalisation: €847k. The latest transaction was filed on 1 July 2026 (Attribution). Among the most active insiders: LIU JEAN I. Every trade is accessible without an account.
6
Insider Decl.
n/a
Thresholds
€319,956
2 ops.
Buy Volume
n/a
n/a
Sell Volume
37Σ signal
Buys €319,956n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
1,160,000 shares@ €2.980891.5% of flowOrdinary SharesSEC:0001193125-26-138012:0
Canonical exit: 29 Jun 2026 (T+90)
6 of 6 declarations
About Connect Biopharma Holdings Ltd
Connect Biopharma Holdings Ltd is a biopharmaceutical company focused on developing treatments for immunological diseases. It is listed on NASDAQ under the symbol CNCT.